External delay spray and preparation method thereof

Through the use of peppercorn peel extract and hydroxy-α-yransaicin lipid microvesicles and 4-tert-butylcyclohexanol liposomes, the problem of poor stability and delay effect of existing external delay sprays is solved. , achieves the stability and cost control of drugs, and has moisturizing, soothing and anti-allergic effects.

CN118986880APending Publication Date: 2024-11-22DIMENG TECH (GUANGDONG) CO LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202411099274.0
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-08-12
Publication Date
2024-11-22

AI Technical Summary

Technical Problem

The existing external delay sprays have problems such as poor drug stability, high cost and poor delay effect, especially the double bond group of the pepper extract is prone to inactivate under light and heat conditions, which affects its stability.

Method used

The liposome and microvesicles are combined with hydroxy-α-yranseacin lipid microvesicles, combined with 4-tert-butyl cyclohexanol liposomes, moisturizers, antiallergic agents and emulsifiers, and the liposome and microvesicles are prepared by preparing liposomes and microvesicles. Improve the delay effect and stability of the spray, and ensure the interaction and dispersion of ingredients through specific ratios and process steps.

Benefits of technology

It has achieved improved stability, cost control and time-lapse improvement of the drug, and has moisturizing, soothing and anti-allergic effects, improving the overall therapeutic effect and comfort of the spray.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure BDA0004988918850000101
    Figure BDA0004988918850000101
Patent Text Reader

Abstract

The invention relates to the technical field of health care products and medicines, in particular to an external delay spray and a preparation method thereof.The external delay spray is prepared from, by weight, 0.1-0.2 part of pepper peel extract, 0.8-1.2 parts of 4-tert-butyl cyclohexanol liposome, 0.2-0.4 part of hydroxyl-alpha-sanshool lipid microbubbles and the balance water. 5-7 parts of a humectant, 2-2.5 parts of an anti-allergic agent, 1-2 parts of an emulsifier and 85-90 parts of a solvent. The external time-delay spray prepared by the invention has the advantages of good drug stability, proper cost and good time-delay effect, and has the effects of moisturizing, relieving and resisting allergy.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention relates to the technical field of health care products and medicines, and in particular to an external delayed spray and a preparation method thereof. Background Art

[0002] With the increasing pressure of life and work, many men are often in a sub-healthy state, leading to problems such as sexual dysfunction, which affects people's quality of life. However, due to closed minds or lack of time, most people often delay treatment in time. Therefore, topical delay sprays quickly gained popularity after they appeared. The principle of delay sprays is very simple. It mainly relies on some pure plant extracts or synthetic compounds in the spray to penetrate into sensitive nerve cells, thereby reducing the sensitivity of the genitals and increasing the stimulation intensity of the emission signal, thereby achieving a certain effect of prolonging the duration of sexual intercourse.

[0003] In the prior art, patent CN110151829A discloses an external delay agent for improving male sexual life time, which helps to improve the use effect of the spray by adding toad extract, gallnut extract and clove extract, and regulating the ratio of toad extract, gallnut extract and clove extract, and can also significantly improve the stability of the spray, and compound Sichuan pepper extract, asarum extract and cnidium monnieri extract can effectively regulate the interaction between them and improve stability. However, the extraction process of toad extract is complicated and the cost is high.

[0004] Patent CN109846953A discloses a male topical delayed ejaculation essence and its application. The essence prepared by combining cocoa seed extract, Morinda officinalis root extract, royal jelly extract, Zanthoxylum bungeanum extract, Cynomorium songaricum extract and deer antler extract can be used as a functional raw material to prepare an external spray or smear, which has the advantages of obvious effect, rapid reaction, long action time and no toxic side effects. However, the Zanthoxylum bungeanum extract contains double bond groups with high activity, which are easily inactivated under various conditions such as light and heat, and have poor stability. When it is prepared into a drug, it will bring great challenges to storage and application.

[0005] Therefore, the market is in urgent need of an external delayed spray with good drug stability, reasonable cost and good delayed effect. Summary of the invention

[0006] In view of the problems existing in the prior art, the purpose of the present invention is to obtain an external delay spray with good drug stability, suitable cost, good delay effect and moisturizing, soothing and anti-allergic effects.

[0007] In order to achieve the above object, the technical solution adopted by the present invention is as follows:

[0008] On the one hand, the present invention provides an external delayed spray, which comprises the following raw materials, measured by weight: 0.1-0.2 parts of Zanthoxylum bungeanum peel extract, 0.8-1.2 parts of 4-tert-butyl cyclohexanol liposomes, 0.2-0.4 parts of hydroxy-α-sanshool lipid microbubbles, 5-7 parts of moisturizers, 2-2.5 parts of antiallergic agents, 1-2 parts of emulsifiers, and 85-90 parts of solvents.

[0009] The external delay spray prepared by the present application using Zanthoxylum bungeanum peel extract, 4-tert-butyl cyclohexanol liposomes, hydroxy-α-sanshool lipid microbubbles, moisturizers, antiallergic agents and emulsifiers, and solvents has good therapeutic effects and moisturizing, soothing and anti-allergic effects.

[0010] Zanthoxylum bungeanum extract contains volatile oil, alkaloids, coumarin, fatty acids and other substances. Its most effective component for delaying effect is hydroxy-α-sanshool. However, the content of hydroxy-α-sanshool is low, so that the delay spray cannot play the maximum effect. The application adds hydroxy-α-sanshool and Zanthoxylum bungeanum peel extract to improve the delay effect of the spray, and prepares hydroxy-α-sanshool into lipid microbubbles so that hydroxy-α-sanshool is not easy to inactivate during transportation and storage, ensuring the efficacy of the product, and its vesicle structure can make hydroxy-α-sanshool lipid microbubbles burst in time when the spray is used under pressure to release hydroxy-α-sanshool, which acts on human cells. After hydroxy-α-sanshool is released, the Zanthoxylum bungeanum extract becomes the "original" solvent of hydroxy-α-sanshool, which makes it easier for hydroxy-α-sanshool to adhere to human cells, and the two interact with each other to further enhance the delay effect.

[0011] 4-tert-butyl cyclohexanol has moisturizing and antibacterial effects, and it can be used as a TRPV1 antagonist to inhibit the occurrence of allergic phenomena, and can significantly reduce the tingling and burning sensations caused by solvents, pepper peel extracts, and hydroxy-α-sanshool lipid microbubbles. However, 4-tert-butyl cyclohexanol can only play the role of a TRPV1 antagonist when it reaches deep into the skin. In this application, 4-tert-butyl cyclohexanol is prepared into liposomes, which can promote 4-tert-butyl cyclohexanol to reach the deep layer of the skin, interact with the cells in the deep layer of the skin, inhibit the activity of TRPV1, and improve the anti-allergic effect.

[0012] In some embodiments, the moisturizer includes the following raw materials in parts by weight: 0.04-0.06 parts of hydrolyzed collagen, 0.57-0.59 parts of arginine, 0.15-0.25 parts of allantoin, 0.14-0.16 parts of colloidal silver, 0.14-0.16 parts of glycine, 0.02-0.04 parts of ethylhexylglycerin, 4-6 parts of propylene glycol, 0.14-0.16 parts of glycerol, 1.8-1.9 parts of Ophiopogon japonicus extract, 0.4-0.6 parts of polyethylene glycol-4, 2.7-3 parts of polyethylene glycol-6, and 0.4-0.6 parts of polyethylene glycol-8.

[0013] The present application compounds various components with moisturizing effects to ensure the moisturizing effect of the external delay spray while bringing additional effects. Among them, hydrolyzed collagen has the effect of fading fine lines; arginine and glycine can promote the synthesis of collagen, reduce the deposition of melanin, and give the skin elasticity and glossiness; allantoin can promote skin regeneration; colloidal silver and ethylhexylglycerin have antibacterial effects. The synergistic effect of various substances can make the external delay spray have antibacterial and repair effects while having moisturizing effects, so that the skin comfort is better after using the product.

[0014] In some embodiments, the antiallergic agent includes the following raw materials in parts by weight: 0.43-0.46 parts of euglena polysaccharide, 0.15-0.25 parts of dipotassium glycyrrhizinate, 0.14-0.16 parts of methylparaben, and 0.25-0.27 parts of phenoxyethanol.

[0015] The present application can bring additional effects while ensuring the anti-allergic effect of the external delay spray by compounding various components with anti-allergic effects. Among them, the microalgae polysaccharide has a sedative and repairing effect; dipotassium glycyrrhizinate has anti-inflammatory and metabolism-promoting effects; methylparaben has a preservative effect; phenoxyethanol has bactericidal and anti-inflammatory effects. The synergistic effect of various substances can make the external delay spray have anti-inflammatory, preservative and other effects while having a moisturizing effect, making the product more effective and easy to store.

[0016] In some embodiments, the emulsifier is a composition of nonylphenol polyether-14 and PEG-50 hydrogenated castor oil, and the mass ratio of the two is 1:(1.1-1.2).

[0017] The present application selects nonylphenol polyether-14 and PEG-50 hydrogenated castor oil to compound an emulsifier, and limits the ratio of the two, so that the external delay spray has good stability and safety. The structure of nonylphenol polyether is similar to estradiol, and it is not easy to affect the female body. The polyethylene glycol segment on the nonylphenol polyether can have good affinity with the polyethylene glycol segment, amide group and hydroxyl group on the hydroxy-α-sanshool lipid microbubble, and improves the compatibility of the hydroxy-α-sanshool lipid microbubble with other substances and the dispersibility in the solvent. PEG-50 hydrogenated castor oil has a good volume-increasing effect, and can disperse the pepper extract and the ophiopogon extract well in the solvent. The volume-increasing agent and the surfactant interact with each other, and the stability of the in vitro delay spray can be improved.

[0018] In some embodiments, the solvent is a mixture of deionized water and anhydrous ethanol, and the mass ratio of the two is 1:(1.6-2).

[0019] In some embodiments, the method for preparing 4-tert-butyl cyclohexanol liposomes comprises the following steps: adding 4-tert-butyl cyclohexanol, ceramide, sodium stearate and ethanol into a reaction container, stirring at 40-50° C. for 20-30 minutes, and obtaining 4-tert-butyl cyclohexanol liposomes after drying.

[0020] The present application prepares 4-tert-butyl cyclohexanol liposomes by reacting 4-tert-butyl cyclohexanol, ceramide and sodium stearate, introduces sodium stearate into the 4-tert-butyl cyclohexanol liposomes, and the long-chain alkyl on the sodium stearate molecular segment has good affinity with the hydrophobic segment on the ceramide, and the anionic group has strong affinity with water and ethanol, which can promote the dispersion of the 4-tert-butyl cyclohexanol liposomes in the system. In addition, the anionic group has an anionic and cationic interaction force with the quaternary ammonium salt group on the hydroxy-α-sanshool lipid microbubble, and the 4-tert-butyl cyclohexanol liposomes and the hydroxy-α-sanshool lipid microbubble are attracted together, so that the 4-tert-butyl cyclohexanol can act on the cells in time to alleviate the irritation of the hydroxy-α-sanshool to the skin.

[0021] In some embodiments, the ceramide is one or more of ceramide 2, ceramide 3, and ceramide 6.

[0022] Preferably, the ceramide is ceramide 6.

[0023] In some embodiments, the mass ratio of 4-tert-butyl cyclohexanol, ceramide, and sodium stearate is 1:(3-5):(0.05-0.15).

[0024] The present application can achieve a higher coverage rate of 4-tert-butyl cyclohexanol by selecting a specific ratio of 4-tert-butyl cyclohexanol and ceramide, and the particle size of the liposome is appropriate, the surface area of ​​the liposome is larger, and the loading amount of sodium stearate is higher. However, the interaction between the stearic acid anion and the quaternary ammonium cation will affect the hydrophilicity of the two groups. The present application can ensure the dispersibility of the liposome in the solvent while increasing the loading amount of sodium stearate by limiting the ratio of sodium stearate, thereby improving the anti-allergic performance of the external delay spray.

[0025] In some embodiments, the hydroxy-α-sanshool lipid microbubbles include the following raw materials, in parts by weight: 8-12 parts of hydroxy-α-sanshool, 35-45 parts of lipid auxiliary materials, 5-10 parts of cholesterol, 7-10 parts of modified phospholipid-anchored polyethylene glycol, 20-22 parts of fluorine-containing inert gas, 70-110 parts of solvent, and 120-220 parts of distilled water;

[0026] The preparation method of the modified phospholipid-anchored polyethylene glycol comprises the following steps:

[0027] A1. Add ethylene oxide, bis(2-hydroxyethyl)amino(trihydroxymethyl)methane, a catalyst and a solvent into a reaction vessel, react at 10-20° C. for 3-4 hours, raise the temperature to 35-45° C., continue to react for 4-8 hours, evaporate the solvent and add the mixture into anhydrous ether, filter and dry the precipitate to obtain modified polyethylene glycol;

[0028] A2, adding the modified polyethylene glycol and toluene obtained in step A1 into a reaction vessel, stirring at room temperature for 20-30 min, adding carbonyldiimidazole, distearoylphosphatidylethanolamine and 4-dimethylaminopyridine, reacting at 55-65° C. for 6-7 h, rotary evaporating the solvent and adding the mixture into anhydrous ether, filtering and drying the precipitate to obtain phospholipid-anchored modified polyethylene glycol;

[0029] A3. Add the phospholipid-anchored modified polyethylene glycol obtained in step A2, 1-bromopropane, ethyl acetate, N,N-dimethylformamide and 4-dimethylaminopyridine into a reaction vessel, heat to 70-90° C. and react for 5-7 hours. After the solvent is evaporated, add the mixture into anhydrous ether. Filter and dry the precipitate to obtain the modified phospholipid-anchored polyethylene glycol.

[0030] In some embodiments, the method for preparing the hydroxy-α-sanshool lipid microbubbles comprises the following steps:

[0031] B1, dissolving hydroxy-α-sanshool, lipid auxiliary material and cholesterol in a solvent to obtain an oil phase;

[0032] B2, dissolving the modified phospholipid-anchored polyethylene glycol in distilled water to obtain an aqueous phase;

[0033] B3, the oil phase obtained in step B1 and the water phase obtained in step B2 are mixed, stirred at room temperature for 60-100 min, and then a fluorine-containing inert gas is introduced at a flow rate of 0.5-3.0 L / min, and hydroxy-α-sanshool lipid microbubbles are obtained after washing and drying.

[0034] In some embodiments, the mass ratio of the oil phase to the water phase is (0.6-0.8):1.

[0035] On the other hand, the present invention provides a method for preparing an external delayed ejaculation spray, comprising the following steps: stirring Zanthoxylum bungeanum peel extract, 4-tert-butyl cyclohexanol liposomes, hydroxy-α-sanshool lipid microbubbles, a moisturizer, an antiallergic agent, and a solvent at 25-35° C. for 5-15 minutes, adding an emulsifier, continuing to stir for 20-30 minutes, filtering and packaging, and standing for 5-10 days to obtain the external delayed ejaculation spray.

[0036] Compared with the prior art, the present invention has the following beneficial effects:

[0037] (1) The external delayed spray prepared by the present invention using Zanthoxylum bungeanum peel extract, 4-tert-butyl cyclohexanol liposomes, hydroxy-α-sanshool lipid microbubbles, moisturizers, antiallergic agents and emulsifiers, and solvents has good therapeutic effects and moisturizing, soothing and anti-allergic effects.

[0038] (2) The present invention can improve the time-delay effect of the spray by compounding hydroxy-α-sanshool lipid microbubbles with Zanthoxylum bungeanum peel extract. After hydroxy-α-sanshool is released, the Zanthoxylum bungeanum extract becomes the "original" solvent of hydroxy-α-sanshool, making it easier for hydroxy-α-sanshool to adhere to human cells. The two interact with each other to further improve the time-delay effect.

[0039] (3) The present invention prepares 4-tert-butyl cyclohexanol into liposomes, which can promote 4-tert-butyl cyclohexanol to reach the deep layer of the skin, act on the cells in the deep layer of the skin, inhibit the activity of TRPV1, and improve the anti-allergic effect. And by reacting 4-tert-butyl cyclohexanol, ceramide and sodium stearate to prepare 4-tert-butyl cyclohexanol liposomes, the dispersion of 4-tert-butyl cyclohexanol liposomes in the system can be promoted. In addition, the stearic acid anion group and the quaternary ammonium salt group on the hydroxy-α-sanshool lipid microbubble have anion-cation interaction force, which attracts the 4-tert-butyl cyclohexanol liposomes and the hydroxy-α-sanshool lipid microbubble together, so that 4-tert-butyl cyclohexanol can act on cells in time to alleviate the stimulation of hydroxy-α-sanshool to the skin. DETAILED DESCRIPTION

[0040] The present invention will be described below in conjunction with specific embodiments. It should be noted that the following embodiments are examples of the present invention and are only used to illustrate the present invention, but not to limit the present invention. Other combinations and various modifications within the concept of the present invention may be performed without departing from the spirit or scope of the present invention.

[0041] In the following examples and comparative examples, except for 4-tert-butyl cyclohexanol liposomes and hydroxy-α-sanshool lipid microbubbles, the other compounds and related reagents used can be purchased from the market, among which hydrolyzed collagen was purchased from Shaanxi Chenming Biotechnology Co., Ltd.; PEG-50 hydrogenated castor oil was purchased from Chengdu Huaxia Chemical Reagent Co., Ltd.; nonylphenol polyether-14 was purchased from Xi'an Kangnuo Chemical Co., Ltd.; microalgae polysaccharide was purchased from Shaanxi Mufan Biotechnology Co., Ltd.; polyethylene glycol-4, polyethylene glycol-6, and polyethylene glycol-8 were purchased from Hai'an Petrochemical Plant in Jiangsu Province; and ceramide 6 was purchased from Fufeng Snot Biotechnology Co., Ltd.

[0042] Preparation Example 1

[0043] The preparation method of 4-tert-butyl cyclohexanol liposome-1 comprises the following steps: adding 1 g of 4-tert-butyl cyclohexanol, 4 g of ceramide 6, 0.1 g of sodium stearate and 10 g of ethanol into a reaction container, stirring at 45° C. for 25 min, and obtaining 4-tert-butyl cyclohexanol liposome-1 after drying.

[0044] Preparation Example 2

[0045] The preparation method of 4-tert-butylcyclohexanol liposome-2 is the same as that of Preparation Example 1, except that the added amount of ceramide 6 is 6 g.

[0046] Preparation Example 3

[0047] The preparation method of 4-tert-butylcyclohexanol liposome-3 is the same as that of Preparation Example 1, except that the added amount of sodium stearate is 0.2 g.

[0048] Preparation Example 4

[0049] The hydroxy-α-sanshool lipid microbubble comprises the following raw materials, in parts by weight: 10 parts of hydroxy-α-sanshool, 40 parts of soybean lecithin, 7 parts of cholesterol, 8 parts of modified phospholipid-anchored polyethylene glycol, 21 parts of perfluoropropane, 90 parts of solvent and 150 parts of distilled water.

[0050] The preparation method of modified phospholipid-anchored polyethylene glycol comprises the following steps:

[0051] A1. Add 10 g of ethylene oxide, 1.7 g of bis(2-hydroxyethyl)amino(trihydroxymethyl)methane, 0.1 g of aluminum isopropoxide and 15 g of distilled water into a reaction vessel, react at 15° C. for 3.5 h, heat to 40° C., continue to react for 6 h, perform rotary evaporation, add 15 g of anhydrous ether, filter and dry to obtain modified polyethylene glycol;

[0052] A2, add 10g of the modified polyethylene glycol obtained in step A1 and 15g of toluene into a reaction container, stir at room temperature for 25min, add 0.82g of N,N'-carbonyldiimidazole, 3.7g of distearoylphosphatidylethanolamine and 0.31g of 4-dimethylaminopyridine, react at 60°C for 6.5h, rotary evaporate, add 20g of anhydrous ether, filter and dry to obtain phospholipid-anchored modified polyethylene glycol;

[0053] A3. Add 10 g of the phospholipid-anchored modified polyethylene glycol obtained in step A2, 0.6 g of 1-bromopropane, 10 g of ethyl acetate, 5 g of N,N-dimethylformamide and 0.1 g of 4-dimethylaminopyridine to a reaction vessel, heat to 80 ° C for reaction, rotary evaporate, add 15 g of anhydrous ether, filter and dry to obtain modified phospholipid-anchored polyethylene glycol.

[0054] The preparation method of hydroxy-α-sanshool lipid microbubbles comprises the following steps:

[0055] B1, dissolving hydroxy-α-sanshool, soybean lecithin and cholesterol in chloroform to obtain an oil phase;

[0056] B2, dissolving the modified phospholipid-anchored polyethylene glycol in distilled water to obtain an aqueous phase;

[0057] B3, the oil phase obtained in step B1 and the water phase obtained in step B2 are mixed, and perfluoropropane is introduced after stirring at room temperature for 80 minutes, and hydroxy-α-sanshool lipid microbubbles are obtained after washing and drying.

[0058] Wherein, the mass ratio of the water phase to the oil phase in step B3 is 1:0.7.

[0059] Preparation Example 5

[0060] The moisturizer comprises the following raw materials, in parts by weight: 0.05 parts of hydrolyzed collagen, 0.58 parts of arginine, 0.2 parts of allantoin, 0.15 parts of colloidal silver, 0.15 parts of glycine, 0.03 parts of ethylhexylglycerin, 5 parts of propylene glycol, 0.15 parts of glycerin, 1.8 parts of ophiopogon japonicus extract, 0.5 parts of polyethylene glycol-4, 2.8 parts of polyethylene glycol-6, and 0.5 parts of polyethylene glycol-8.

[0061] The preparation method of the moisturizer is as follows: hydrolyzed collagen, arginine, allantoin, colloidal silver, glycine, ethylhexylglycerin, propylene glycol, glycerin, ophiopogon japonicus extract, polyethylene glycol-4, polyethylene glycol-6, and polyethylene glycol-8 are added into a mixer and mixed at room temperature for 20 minutes.

[0062] Preparation Example 6

[0063] The antiallergic agent comprises the following raw materials, measured in parts by weight: 0.45 parts of fine algae polysaccharide, 0.2 parts of dipotassium glycyrrhizinate, 0.15 parts of methylparaben, and 0.26 parts of phenoxyethanol.

[0064] The preparation method of the antiallergic agent is as follows: adding microalgae polysaccharide, dipotassium glycyrrhizinate, methylparaben and phenoxyethanol into a mixer and mixing at room temperature for 20 minutes.

[0065] Preparation Example 7

[0066] The preparation method of the emulsifier is as follows: 10 g of nonylphenol polyether-14 and 11.5 g of PEG-50 hydrogenated castor oil are added into a container and stirred at room temperature for 30 minutes.

[0067] Example 1

[0068] A topical delayed ejaculation spray comprises the following raw materials, measured by weight: 0.15 parts of Zanthoxylum bungeanum peel extract, 1 parts of 4-tert-butylcyclohexanol liposome-1, 0.3 parts of hydroxy-α-sanshool lipid microbubbles, 6 parts of moisturizer, 2.2 parts of antiallergic agent, 1.5 parts of emulsifier and 87 parts of solvent.

[0069] The preparation method of the external delay spray of the present embodiment comprises the following steps: stirring the Zanthoxylum bungeanum peel extract, 4-tert-butylcyclohexanol liposome-1, hydroxy-α-sanshool lipid microbubbles, a moisturizer, an antiallergic agent, and a solvent at 30° C. for 10 minutes, adding an emulsifier, continuing to stir for 25 minutes, filtering and packaging, and standing for 7 days to obtain the external delay spray.

[0070] The solvent is a mixture of water and anhydrous ethanol, and the mass ratio of the two is 1:1.6.

[0071] Example 2

[0072] A topical delayed ejaculation spray comprises the following raw materials, measured by weight: 0.1 parts of Zanthoxylum bungeanum peel extract, 0.8 parts of 4-tert-butylcyclohexanol liposome-1, 0.2 parts of hydroxy-α-sanshool lipid microbubbles, 5 parts of moisturizer, 2 parts of antiallergic agent, 1 part of emulsifier and 85 parts of solvent.

[0073] The preparation method of the external delay spray of the present embodiment comprises the following steps: stirring the Zanthoxylum bungeanum peel extract, 4-tert-butylcyclohexanol liposome-1, hydroxy-α-sanshool lipid microbubbles, a moisturizer, an antiallergic agent, and a solvent at 25° C. for 15 minutes, adding an emulsifier, continuing to stir for 20 minutes, filtering and packaging, and standing for 5 days to obtain the external delay spray.

[0074] The solvent is a mixture of water and anhydrous ethanol, and the mass ratio of the two is 1:1.8.

[0075] Example 3

[0076] A topical delayed ejaculation spray comprises the following raw materials, measured by weight: 0.1 parts of Zanthoxylum bungeanum peel extract, 0.8 parts of 4-tert-butylcyclohexanol liposome-1, 0.2 parts of hydroxy-α-sanshool lipid microbubbles, 5 parts of moisturizer, 2 parts of antiallergic agent, 1 part of emulsifier and 85 parts of solvent.

[0077] The preparation method of the external delay spray of the present embodiment comprises the following steps: stirring the Zanthoxylum bungeanum peel extract, 4-tert-butylcyclohexanol liposome-1, hydroxy-α-sanshool lipid microbubbles, a moisturizer, an antiallergic agent, and a solvent at 35° C. for 5 minutes, adding an emulsifier, continuing to stir for 30 minutes, filtering and packaging, and standing for 10 days to obtain the external delay spray.

[0078] The solvent is a mixture of water and anhydrous ethanol, and the mass ratio of the two is 1:2.

[0079] Example 4

[0080] A topical delayed ejaculation spray and a preparation method thereof. The specific implementation method is the same as that of Example 1, except that an equal amount of 4-tert-butyl cyclohexanol liposome-1 is replaced by 4-tert-butyl cyclohexanol liposome-2.

[0081] Example 5

[0082] A topical delayed ejaculation spray and a preparation method thereof. The specific implementation manner is the same as that of Example 1, except that an equal amount of 4-tert-butyl cyclohexanol liposome-1 is replaced by 4-tert-butyl cyclohexanol liposome-3.

[0083] Comparative Example 1

[0084] A topical delayed ejaculation spray and a preparation method thereof. The specific implementation manner is the same as that of Example 1, except that an equal amount of 4-tert-butyl cyclohexanol liposome-1 is replaced by 4-tert-butyl cyclohexanol.

[0085] Comparative Example 2

[0086] An external delayed ejaculation spray and a preparation method thereof, wherein the specific implementation manner is the same as that of Example 1, except that no Zanthoxylum bungeanum peel extract is added.

[0087] Comparative Example 3

[0088] A topical delayed ejaculation spray and a preparation method thereof. The specific implementation manner is the same as that of Example 1, except that an equal amount of hydroxy-α-sanshool lipid microbubbles is replaced with hydroxy-α-sanshool.

[0089] Performance Testing

[0090] The external delay sprays obtained in the above embodiments and comparative examples were subjected to clinical effect tests:

[0091] (1) Anti-allergic property: The external delayed ejaculation spray prepared in the present invention was sprayed on the glans penis of 33 adult male rabbits, with 3 rabbits in each group, and 0.05 g was sprayed each time. The spray was applied once every 10 minutes for 5 times. The glans penis was cut off at 30 minutes, 1 hour, 2 hours, 4 hours, and 8 hours after spraying for pathological histological examination to determine whether there was any abnormality;

[0092] (2) Delay effect: In this clinical trial, 55 volunteers with premature ejaculation were selected, each with 5 people in a group, and agreed to use the reagent prepared in the above example for clinical research treatment. The average age of the volunteers was 40.2 years (30-60 years old), and the onset time was 17.5 years (5-10 years).

[0093] The patient lies in a supine position with eyes closed. The examiner randomly stimulates the glans penis, scrotum, and inner thigh of the patient with a common cotton thread, and asks the patient to confirm the stimulated area. Patients who can identify each stimulated area are included in this study and their results are recorded. Then, using Biothegiometry, electrodes are placed on the ventral side of the index finger, glans penis, inner thigh, and scrotum, and the current is gradually increased until the patient can feel the local oscillation and the displayed data is recorded.

[0094] Before spraying, confirm that all patients can recognize the cotton thread stimulation of the glans penis, scrotum, and inner thigh. Take about 0.2g of the external delay spray of the present invention and spray it on the glans penis of the patient. Repeat the above examination after 1 hour and record the results. After 1 hour, check whether the tactile sensation of the glans penis disappears or decreases, and whether the glans penis grows. The test results are shown in Table 1:

[0095] Table 1

[0096]

[0097]

[0098] It can be seen from the data in Table 1 that the external delay sprays in Examples 1-3 of the present invention have good anti-allergic properties and delayed effects; from the comparison of Examples 4 and 5 with Example 1, it can be seen that changing the ratio of ceramide or sodium stearate will make the loading amount of sodium stearate too high, and the hydrophilicity of 4-tert-butyl cyclohexanol liposomes will decrease; from the comparison of Comparative Example 1 and Example 1, it can be seen that directly using 4-tert-butyl cyclohexanol, the anti-allergic property of the in vitro delay spray is poor; from the comparison of Comparative Example 2 and Example 1, it can be seen that without adding the zanthoxylum peel extract, the adhesion of hydroxyl-α-sanshool on the skin will be reduced, making the delayed effect worse; from the comparison of Comparative Example 2 and Example 1, it can be seen that without adding the zanthoxylum peel extract, the adhesion of hydroxyl-α-sanshool on the skin will be reduced, making the delayed effect worse; from the comparison of Comparative Example 3 and Example 1, it can be seen that replacing the hydroxyl-α-sanshool lipid microbubbles with hydroxyl-α-sanshool in equal amounts will make the delayed effect of the external delay spray worse.

[0099] The above implementation modes are only for illustrating the technical concept and features of the present invention, and their purpose is to enable people familiar with this technology to understand the content of the present invention and implement it, and they cannot be used to limit the protection scope of the present invention. Any equivalent changes or modifications made according to the spirit of the present invention should be included in the protection scope of the present invention.

Claims

1. An external delayed spray, characterized in that: In parts by weight, the following raw materials are included: 0.1-0.2 parts of Zanthoxylum bungeanum peel extract, 0.8-1.2 parts of 4-tert-butyl cyclohexanol liposomes, 0.2-0.4 parts of hydroxy-α-sanshool lipid microbubbles, 5-7 parts of moisturizing agents, 2-2.5 parts of antiallergic agents, 1-2 parts of emulsifiers, and 85-90 parts of solvents.

2. The external delay spray according to claim 1, characterized in that: The moisturizing agent comprises the following raw materials, in parts by weight: 0.04-0.06 parts of hydrolyzed collagen, 0.57-0.59 parts of arginine, 0.15-0.25 parts of allantoin, 0.14-0.16 parts of colloidal silver, 0.14-0.16 parts of glycine, 0.02-0.04 parts of ethylhexylglycerol, 4-6 parts of propylene glycol, 0.14-0.16 parts of glycerol, 1.8-1.9 parts of ophiopogon japonicus extract, 0.4-0.6 parts of polyethylene glycol-4, 2.7-3 parts of polyethylene glycol-6, and 0.4-0.6 parts of polyethylene glycol-8.

3. The external delay spray according to claim 1, characterized in that: The antiallergic agent comprises the following raw materials, in parts by weight: 0.43-0.46 parts of euglena polysaccharide, 0.15-0.25 parts of dipotassium glycyrrhizinate, 0.14-0.16 parts of methylparaben, and 0.25-0.27 parts of phenoxyethanol.

4. The external use delay spray according to claim 1, characterized in that: The emulsifier is a composition of nonylphenol polyether-14 and PEG-50 hydrogenated castor oil, and the mass ratio of the two is 1:(1.1-1.2).

5. The external use delay spray according to claim 1, characterized in that: The solvent is a mixture of deionized water and anhydrous ethanol, and the mass ratio of the two is 1:(1.6-2).

6. The external use delay spray according to claim 1, characterized in that: The preparation method of 4-tert-butyl cyclohexanol liposomes comprises the following steps: adding 4-tert-butyl cyclohexanol, ceramide, sodium stearate and ethanol into a reaction container, stirring at 40-50° C. for 20-30 minutes, and drying to obtain 4-tert-butyl cyclohexanol liposomes.

7. The external use delay spray according to claim 6, characterized in that: The ceramide is one or more of ceramide 2, ceramide 3, and ceramide 6.

8. The external use delay spray according to claim 6, characterized in that: The mass ratio of the 4-tert-butyl cyclohexanol, ceramide and sodium stearate is 1:(3-5):(0.05-0.15).

9. The external use delay spray according to claim 1, characterized in that: The hydroxy-α-sanshool lipid microbubble is characterized in that it comprises the following raw materials, in parts by weight: 8-12 parts of hydroxy-α-sanshool, 35-45 parts of lipid auxiliary materials, 5-10 parts of cholesterol, 7-10 parts of modified phospholipid-anchored polyethylene glycol, 20-22 parts of fluorine-containing inert gas, 70-110 parts of solvent, and 120-220 parts of distilled water.

10. A method for preparing the external delayed spray according to any one of claims 1 to 9, characterized in that: The method comprises the following steps: stirring the Zanthoxylum bungeanum peel extract, 4-tert-butyl cyclohexanol liposomes, hydroxy-α-sanshool lipid microbubbles, moisturizer, antiallergic agent and solvent at 25-35°C for 5-15 minutes, adding an emulsifier, continuing to stir for 20-30 minutes, filtering and packaging, and standing for 5-10 days to obtain an external delay spray.